D.R.Nano Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 1

D.R.Nano General Information

Description

Provider of a research and development platform intended to provide non-invasive medical approaches based on physicochemical convergence technologies. The company's platform uses nano repositioning beyond salt exchange technology and specializes in the research and development of advanced technology products targeting a wide range of fields such as skin diseases, eye disease, cosmeceuticals, and cancer, enabling users to reduce adverse reactions and convenient skin disease photodynamic therapeutic agents.

Contact Information

Website
www.dr-nano.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 4, 4th floor
  • 168 Magokjungang-ro
  • Seoul, Songpa-gu 05842
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Number 4, 4th floor
  • 168 Magokjungang-ro
  • Seoul, Songpa-gu 05842
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

D.R.Nano Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 01-Mar-2024 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2019 Completed Generating Revenue
To view D.R.Nano’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

D.R.Nano Patents

  • 22

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • Pending

  • Expiring in next 12 mo

D.R.Nano Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022245032-A1 Photoresponsive micelle complex for prevention or treatment of inflammatory disease or infectious disease Inactive 17-May-2021
WO-2021242070-A1 Photoreactive cosmetic composition for enhancing skin elasticity and reducing skin wrinkles, and preparation method therefor Inactive 29-May-2020
JP-2019126713-A Patch-type wound dressing comprising methylene blue mixture Active 22-Jan-2018
EP-3513819-A1 Patch-type wound dressing comprising methylene blue mixture for treating skin wound Active 22-Jan-2018
EP-3513819-B1 Patch-type wound dressing comprising methylene blue mixture for treating skin wound Inactive 22-Jan-2018 A61F13/00063
To view D.R.Nano’s complete patent history, request access »

D.R.Nano Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innocube Accelerator/Incubator
To view D.R.Nano’s complete investors history, request access »

Ready to get started?

Request a free trial

D.R.Nano FAQs

  • When was D.R.Nano founded?

    D.R.Nano was founded in 2015.

  • Where is D.R.Nano headquartered?

    D.R.Nano is headquartered in Seoul, South Korea.

  • What industry is D.R.Nano in?

    D.R.Nano’s primary industry is Drug Discovery.

  • Is D.R.Nano a private or public company?

    D.R.Nano is a Private company.

  • What is D.R.Nano’s current revenue?

    The current revenue for D.R.Nano is .

  • Who are D.R.Nano’s investors?

    Innocube has invested in D.R.Nano.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process